CLINICAL_TRIALS
trial_result
· 2025-07-11
Clinical Trial Update: SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study) [Phase 3]
Summary
A Phase 3 trial of SI-6603 (Condoliase) for lumbar disc herniation has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seikagaku Corporation | Conditions: Lumbar Disc Herniation | Phase 3 | Status: COMPLETED | Results posted: 2025-07-11